TBPH (Theravance Biopharma) חוב לטווח קצר להון
The global distribution of respiratory treatments relies on established supply chains, ensuring medication availability in pharmacies. The price trend on GURU.Markets, where the indicator equals 0.03, links logistics to partnerships with industry behemoths for joint product promotion. Meanwhile, steady demand for lung treatments ensures a stable cash flow, supporting the operational activity of Theravance Biopharma (TBPH).
פילוחים אנליטיים של חברת Theravance Biopharma
Through partnerships with pharma giants and the receipt of royalties, Theravance Biopharma (TBPH) minimizes operating expenses, which directly impacts its short-term financial leverage ratio. This metric compares liabilities with maturities of up to one year against total equity to measure immediate liquidity and resilience to cash flow gaps, allowing investors to assess the balance between financial security and the efficiency of borrowed fund utilization.